These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
152 related items for PubMed ID: 16579401
1. Effect of Sahaj Yoga on depressive disorders. Sharma VK, Das S, Mondal S, Goswampi U, Gandhi A. Indian J Physiol Pharmacol; 2005; 49(4):462-8. PubMed ID: 16579401 [Abstract] [Full Text] [Related]
3. Emotional withdrawal, CT abnormalities and drug response in late life depression. Altamura AC, Bassetti R, Santini A, Frisoni GB, Mundo E. Prog Neuropsychopharmacol Biol Psychiatry; 2004 Mar; 28(2):349-54. PubMed ID: 14751432 [Abstract] [Full Text] [Related]
5. Residual symptoms in bipolar disorder: the effect of the last episode after remission. Kaya E, Aydemir O, Selcuki D. Prog Neuropsychopharmacol Biol Psychiatry; 2007 Oct 01; 31(7):1387-92. PubMed ID: 17628288 [Abstract] [Full Text] [Related]
6. Subsyndromal depressive symptoms in patients with bipolar and unipolar disorder during clinical remission. Vieta E, Sánchez-Moreno J, Lahuerta J, Zaragoza S, EDHIPO Group (Hypomania Detection Study Group). J Affect Disord; 2008 Apr 01; 107(1-3):169-74. PubMed ID: 17870184 [Abstract] [Full Text] [Related]
7. Eszopiclone co-administered with fluoxetine in patients with insomnia coexisting with major depressive disorder. Fava M, McCall WV, Krystal A, Wessel T, Rubens R, Caron J, Amato D, Roth T. Biol Psychiatry; 2006 Jun 01; 59(11):1052-60. PubMed ID: 16581036 [Abstract] [Full Text] [Related]
8. Association between improvement in depression, reduced benzodiazepine (BDZ) abuse, and increased psychotropic medication use in methadone maintenance treatment (MMT) patients. Schreiber S, Peles E, Adelson M. Drug Alcohol Depend; 2008 Jan 01; 92(1-3):79-85. PubMed ID: 17706374 [Abstract] [Full Text] [Related]
9. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study. Spencer TJ, Wilens TE, Biederman J, Weisler RH, Read SC, Pratt R. Clin Ther; 2006 Feb 01; 28(2):266-79. PubMed ID: 16678648 [Abstract] [Full Text] [Related]
11. Comparison of Hypericum extract WS 5570 and paroxetine in ongoing treatment after recovery from an episode of moderate to severe depression: results from a randomized multicenter study. Anghelescu IG, Kohnen R, Szegedi A, Klement S, Kieser M. Pharmacopsychiatry; 2006 Nov 01; 39(6):213-9. PubMed ID: 17124643 [Abstract] [Full Text] [Related]
16. Comparison of efficacy and tolerability of reboxetine and venlafaxine XR in major depression and major depression with anxiety features: an open label study. Akkaya C, Sivrioglu EY, Akgoz S, Eker SS, Kirli S. Hum Psychopharmacol; 2006 Jul 01; 21(5):337-45. PubMed ID: 16856215 [Abstract] [Full Text] [Related]
17. Mood disorders after stroke: diagnostic validation of the poststroke depression rating scale. Quaranta D, Marra C, Gainotti G. Cerebrovasc Dis; 2008 Jul 01; 26(3):237-43. PubMed ID: 18648195 [Abstract] [Full Text] [Related]